| Primary |
| Psoriasis |
36.7% |
| Drug Use For Unknown Indication |
15.3% |
| Product Used For Unknown Indication |
12.2% |
| Osteoarthritis |
4.1% |
| Pityriasis Rubra Pilaris |
4.1% |
| Acne |
3.1% |
| Hiv Infection |
3.1% |
| Pustular Psoriasis |
3.1% |
| Cellulitis |
2.0% |
| Depression |
2.0% |
| Eczema |
2.0% |
| Erythrodermic Psoriasis |
2.0% |
| Hypertension |
2.0% |
| Hypothyroidism |
2.0% |
| Abdominal Discomfort |
1.0% |
| Antidepressant Therapy |
1.0% |
| Basal Cell Carcinoma |
1.0% |
| Hyperkeratosis |
1.0% |
| Ichthyosis |
1.0% |
| Leukoplakia Oral |
1.0% |
|
| Drug Exposure During Pregnancy |
20.0% |
| Skin Exfoliation |
8.9% |
| Diabetes Mellitus |
6.7% |
| Drug Exposure Before Pregnancy |
6.7% |
| Pregnancy |
6.7% |
| Alopecia |
4.4% |
| Pain In Extremity |
4.4% |
| Psoriasis |
4.4% |
| Pyrexia |
4.4% |
| Retinal Detachment |
4.4% |
| Sticky Skin |
4.4% |
| Vertigo |
4.4% |
| Vision Blurred |
4.4% |
| Angioedema |
2.2% |
| Atrioventricular Block Complete |
2.2% |
| Azoospermia |
2.2% |
| Colitis |
2.2% |
| Endometrial Cancer |
2.2% |
| Exposure During Pregnancy |
2.2% |
| Exposure Via Body Fluid |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
37.8% |
| Drug Use For Unknown Indication |
28.6% |
| Psoriasis |
12.2% |
| Pustular Psoriasis |
8.2% |
| Pain |
5.1% |
| Pityriasis Rubra Pilaris |
4.1% |
| Psoriatic Arthropathy |
4.1% |
|
| Pain In Extremity |
21.1% |
| Vomiting |
21.1% |
| Skin Exfoliation |
15.8% |
| Multiple Myeloma |
10.5% |
| Acute Myocardial Infarction |
5.3% |
| Cerebral Infarction |
5.3% |
| Maternal Exposure During Pregnancy |
5.3% |
| Metastases To Bone |
5.3% |
| Pregnancy |
5.3% |
| Tendonitis |
5.3% |
|
| Concomitant |
| Psoriasis |
31.4% |
| Psoriatic Arthropathy |
9.2% |
| Product Used For Unknown Indication |
8.6% |
| Pustular Psoriasis |
8.6% |
| Essential Hypertension |
6.5% |
| Personality Disorder |
6.5% |
| Ill-defined Disorder |
4.9% |
| Pain |
3.8% |
| Drug Use For Unknown Indication |
3.2% |
| Back Pain |
2.2% |
| Hyperkeratosis |
2.2% |
| Hypertension |
2.2% |
| Pain In Extremity |
2.2% |
| Diabetes Mellitus |
1.6% |
| Keratosis Follicular |
1.6% |
| Antibiotic Prophylaxis |
1.1% |
| Atrophic Vulvovaginitis |
1.1% |
| Benign Prostatic Hyperplasia |
1.1% |
| Dry Skin |
1.1% |
| Hepatic Steatosis |
1.1% |
|
| Urticaria |
10.5% |
| Hemiparesis |
7.9% |
| Psoriasis |
7.9% |
| Squamous Cell Carcinoma |
7.9% |
| Urinary Tract Infection |
7.9% |
| Vomiting |
7.9% |
| Hodgkin's Disease Stage Ii |
5.3% |
| Pancreatitis |
5.3% |
| Pustular Psoriasis |
5.3% |
| Pyrexia |
5.3% |
| Toxic Epidermal Necrolysis |
5.3% |
| Acute Myocardial Infarction |
2.6% |
| Chills |
2.6% |
| Cognitive Disorder |
2.6% |
| Cryoglobulinaemia |
2.6% |
| Death |
2.6% |
| Dyspnoea |
2.6% |
| Eye Movement Disorder |
2.6% |
| Eyelid Ptosis |
2.6% |
| H1n1 Influenza |
2.6% |
|
